Product Description: PD-1/PD-L1-IN-42 (Compound B8.4) is an inhibitor of the interaction between PD-1 and PD-L1, with an EC50 of 0.1 μM. PD-1/PD-L1-IN-42 can be used for the research of cancer immunotherapy[1].
Formula: C85H129N21O24S
References: [1]Tseng TS, et al. Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering. J Chem Inf Model. 2024;64(5):1615-1627.
Molecular Weight: 1861.13
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: PD-1/PD-L1